Symphony Share Price Surges 7% as it Plans to Enter AC, Ceiling Fan and Air Purifier Markets

Symphony Limited is planning to expand beyond air coolers in India. The company will start selling room air conditioners, BLDC ceiling fans and air purifiers as part of a phased rollout, as per the exchange filing.  

The new products are planned to be introduced from the December 2026 quarter. Symphony said it will start with selected products, markets and sales channels instead of launching everything at once.  

Symphony to Add Three New Product Categories 

The company plans to enter three categories — room air conditioners, BLDC ceiling fans and air purifiers. This will give Symphony more products to sell in the Indian consumer-durables market.  

No New Manufacturing Plant Planned 

Symphony said it currently does not plan to set up its own manufacturing facilities for these products. The expansion will follow an asset-light model. 

The company plans to use its internal funds gradually for product development, inventory, marketing, distribution, service support, and working capital.  

Products to Launch from December 2026 Quarter 

The rollout is expected to begin from the December 2026 quarter. Symphony said the pace of the expansion will depend on how customers respond to the products and how ready the company is to sell and service them.  

Read More: HDFC Bank Share Price in Focus as Bank Cuts MCLR by Upto 10 Basis Points Effective September 7, 2026! 

Symphony Share Price Performance 

As of September 08, 2026, at 11:28 AM, Symphony share price was trading at ₹613.15 per share, reflecting a surge of 6.93% from the previous trading session. 

Conclusion 

Symphony is adding room air conditioners, BLDC ceiling fans and air purifiers to its India product portfolio. The company plans to begin the rollout from the December 2026 quarter without setting up in-house manufacturing facilities at present.  

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.